CDC NEWS


powered by Surfing Waves


Latest News


Maintaining Safety with SARS-CoV-2 Vaccines


30 Dec 2020

To date, the development of mRNA vaccines for the prevention of infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a success story, with no serious concerns identified in the ongoing phase 3 clinical trials


An Essential Worker’s List of Pandemic Chores for the Kids


29 Dec 2020

Sorry I had to leave before you woke up. You’re right, it isn’t fair. Please empty the dishwasher today. And brush your teeth. Remember to feed the dog. He will die if no one remembers to do this.


Phase 3 trial of Novavax investigational COVID-19 vaccine opens


28 Dec 2020

The Phase 3 trial of another investigational coronavirus disease 2019 (COVID-19) vaccine has begun enrolling adult volunteers. The randomized, placebo-controlled trial will enroll approximately 30,000 people at approximately 115 sites in the United States and Mexico. It will evaluate the safety and efficacy of NVX-CoV2373, a vaccine candidate developed by Novavax, Inc., of Gaithersburg, Maryland. Novavax is leading the trial as the regulatory sponsor.


Older Adults’ Perspectives on a COVID-19 Vaccine


23 Dec 2020

As of December 4, 2020, cases of novel coronavirus disease 2019 (COVID-19) have topped 14.3 million in the US with nearly 300 000 associated deaths. While mitigation measures such as social distancing, use of face coverings, and avoidance of crowds can help keep case counts in check, a safe and effective COVID-19 vaccine will be essential to ending the pandemic.


Coronavirus Vaccines


02 Oct 2020

Leading COVID-19 vaccine candidates rely on new genetic technologies that have fast-tracked development and testing. This video explains the principles underlying the leading DNA, messenger RNA (mRNA), and viral vector vaccine candidates, and how they might induce immunity to SARS-CoV-2 infection.




Articles


Both Remote and On-Site Workers are Grappling with Serious Mental Health Consequences of COVID-19


22 Dec 2020

While millions have recently lost their jobs or income and face new stresses, many who have been during the pandemic also face new pressures.




The lightning-fast quest for COVID vaccines — and what it means for other diseases


18 Dec 2020

The speedy approach used to tackle SARS-CoV-2 could change the future of vaccine science.




Trusted Messengers May Help Disenfranchised Communities Overcome Vaccine Hesitancy


17 Dec 2020

MINNEAPOLIS — Gloria Torres-Herbeck gets the flu vaccine every year, but the 53-year-old teacher in Rochester, Minnesota, isn’t yet convinced she wants to be first in line for a potential COVID-19 vaccine.




Enroll for Free